Aldolase B inhibits metastasis through Ten–Eleven Translocation 1 and serves as a prognostic biomarker in hepatocellular carcinoma
2015 · Molecular Cancer · 84 citations
https://doi.org/10.1186/s12943-015-0437-7
S
Shengxian Yuan
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
128
Papers
5.3K
Citations
34
h-index
58
i10-index
Shengxian Yuan is an academic researcher from Second Military Medical University. The author has contributed to research in topics: RNA modifications and cancer & Hepatocellular Carcinoma Treatment and Prognosis & Advanced Breast Cancer Therapies. The author has an h-index of 34, co-authored 109 publications.
ORCID: 0000-0002-4883-0156Papers by this author
worksPioglitazone, a PPARγ agonist, inhibits growth and invasion of human hepatocellular carcinoma via blockade of the rage signaling
2014 · Molecular Carcinogenesis · 55 citations
https://doi.org/10.1002/mc.22231
Paradoxical Activation of Oncogenic Signaling as a Cancer Treatment Strategy
2024 · Cancer Discovery · 44 citations
https://doi.org/10.1158/2159-8290.cd-23-0216
DNA hypermethylation modification promotes the development of hepatocellular carcinoma by depressing the tumor suppressor gene ZNF334
2022 · Cell Death and Disease · 34 citations
https://doi.org/10.1038/s41419-022-04895-6
Development and comprehensive validation of a predictive prognosis model for very early HCC recurrence within one year after curative resection: a multicenter cohort study
2024 · International Journal of Surgery · 21 citations
https://doi.org/10.1097/js9.0000000000001467
Laparoscopic right hemihepatectomy following a novel optimized portal vein embolization: a video case report
2022 · BMC Gastroenterology · 1 citations
https://doi.org/10.1186/s12876-022-02321-x
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat